No. of Recommendations: 4
Moderna issued an expansive press release this morning which updated their pipeline and gave some guidance on near future expectations for revenue from their respiratory vaccines.
I wrote up a summary and thoughts on the more interesting bits here on the Shrewd Moderna board:
BenSolar writes on Moderna Pipeline UpdatePress release here:
finance.yahoo.com - Moderna announces clinical program updatesIt's an exciting business with a potentially huge future, IMO. They've been wildly profitable the last year or so due to their blockbuster Covid vaccine, but with that business slowing down and future drugs and vaccines in the pipeline not quite ready for commercialization, they're expected to turn to a loss in the coming quarter, current year and next year.
